Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice

FEMS Immunology and Medical Microbiology

Volumn 29, Issue 4, 2000, Pages 255-261

  El Ghorr, Ali A ^a   Williams, Rhodri M ^a   Heap, Caroline ^a   Norval, Mary ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Herpes simplex virus; Mouse; T and B cell response to herpes simplex virus; Transcutaneous immunisation

Indexed keywords

BOVINE SERUM ALBUMIN; CHOLERA TOXIN; HERPES SIMPLEX VACCINE; IMMUNOLOGICAL ADJUVANT; VIRUS ANTIBODY; VIRUS ANTIGEN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG POTENCY; FECES LEVEL; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; LANGERHANS CELL; LEUKOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOPICAL TREATMENT; TREATMENT OUTCOME; VACCINE PRODUCTION; VERO CELL; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; CHOLERA TOXIN; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, MUCOSAL; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; T-LYMPHOCYTES; VACCINATION; VACCINES, INACTIVATED;

EID: 85048645485     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2000.tb01531.x     Document Type: Article

References (27)

1. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits
2. Herpes simplex viruses
3. Evaluation of herpes simplex virus vaccine in animals: The guinea pig vaginal model
4. Herpes simplex virus glycoprotein treatment of recurrent genital herpes
5. Skin immunization made possible by cholera toxin
6. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge
7. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
8. Comparative potency of different UV sources in reducing the density and antigen-presenting capacity of Langerhans cells in C3H mice
9. Exposure to low dose ultraviolet B light suppresses delayed hypersensitivity to herpes simplex virus in mice
10. The effect of UV-B irradiation on secondary epidermal infection of mice with herpes simplex virus type 1
11. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections
12. Rodent epidermal Langerhans cells demonstrate greater histochemical specificity for ADP than for ATP and AMP
13. Appraisal of gut lavage in the study of intestinal humoral immunity
14. The effect of UV-B irradiation on antibody responses to herpes simplex virus type 1 infections of mice
15. Urocanic acid analogues and the suppression of delayed type hypersensitivity response to herpes simplex virus
16. The effect of UV-B irradiation on the course of primary and secondary HSV-1 Infections in interleukin-4 knockout mice
17. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones
18. Role of mucosal immunity in herpes simplex virus infection
19. Herpes simplex virus vaccines
20. The role of neutralising antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge
21. The acquisition of herpes simplex virus during pregnancy
22. Specific and non-specific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge
23. Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function
24. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease
25. Role of antibody in primary and recurrent herpes simplex virus infection
26. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells
27. The mechanism of cholera toxin adjuvanticity